Quarterly report pursuant to Section 13 or 15(d)

Leases

v3.22.2.2
Leases
9 Months Ended
Sep. 30, 2022
Leases [Abstract]  
Leases
Note 2 – Leases
The Company mainly leases office space and cannabis cultivation, processing and retail dispensary space. Leases with an initial term of less than 12 months are not recorded on the unaudited interim condensed consolidated balance sheets. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Most leases include one or more options to renew, with renewal terms that can extend the lease term from one to five years or more. The Company has determined that it was reasonably certain that the renewal options on the majority of its cannabis cultivation, processing and retail dispensary space would be exercised based on operating history and knowledge, current understanding of future business needs and the level of investment in leasehold improvements, among other considerations. The incremental borrowing rate used in the calculation of the lease liability is based on the rate available to the parent company. The depreciable life of assets and leasehold improvements are limited by the expected lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. Certain subsidiaries of the Company rent or sublease certain office space to/from other subsidiaries of the Company. These intercompany subleases are eliminated on consolidation and have lease terms ranging from less than
one
year to 15 years.
Maturities of lease liabilities for operating leases as of September 30, 2022, were as follows:
 
    
Operating
Leases
 
2023
   $ 7,710  
2024
     7,817  
2025
     7,942  
2026
     7,867  
2027
     7,287  
Thereafter
     56,640  
    
 
 
 
Total lease payments
   $ 95,263  
Less: interest expense
     (58,492
    
 
 
 
Present value of lease liabilities
   $ 36,771  
Weighted-average remaining lease term (years)
     11.3  
Weighted-average discount rate
     20
    
 
 
 
For the three and nine months ended September 30, 2022, the Company recorded operating lease expenses of $2.1 million and $6.4 million, respectively (September 30, 2021—$2.1 million and $6.5 million, respectively), which are included in selling, general and administrative expenses on the unaudited interim condensed consolidated statements of operations.
The Company has entered into multiple sublease agreements pursuant to which it serves as lessor to the sublessees. The gross rental income and underlying lease expense are presented gross on the Company’s unaudited interim condensed consolidated balance sheets. For the three and nine months ended September 30, 2022, the Company recorded sublease income of $0.2 million and $0.7 million, respectively (September 30, 2021 – $0.2 million and $0.3 million, respectively), which is included in other income on the unaudited interim condensed consolidated statements of operations. The Company recorded impairment loss for its
right-of-use
assets of $Nil and $Nil
 for the three and nine months ended September 30, 2022, respectively (September 30, 2021—$
0.1 million and $1.8 million, respectively).
Supplemental balance sheet information related to leases are as follows:
 
Balance Sheet Information
  
Classification
  
September 30,
2022
    
December 31,
2021
 
Right-of-use
assets
  
Operating leases
   $  31,854      $  30,429  
Lease liabilities
                      
Current portion of lease liabilities
   Operating leases    $ 7,710      $ 7,342  
Long-term lease liabilities
   Operating leases      29,061        27,814  
         
 
 
    
 
 
 
Total
       
$
36,771
 
  
$
35,156